This yielded 710 total patients with overweight, 1,515 total patients with obesity and 1,249 total patients with morbid obesity
[1] [2] These conditions are replicated in the licensed prescribing information to ensure patients receive the intended therapeutic benefit
In fact, among the various neurochemical systems involved in wakefulness (acetylcholine, norepinephrine, dopamine, serotonin, histamine), the hypothalamic orexigenic neurons are crucial promoters of wakefulness since deficiency in the orexin system leads to disorders such as narcolepsy (Modirrousta et al., 2005)
Stimulates muscle protein synthesis | Reduces muscle catabolism
A patient with lower GLP1R pathway activation might benefit more from tirzepatide's dual-peptide action (which targets both GLP-1 and GIP receptors), while someone with strong GLP1R sensitivity may achieve excellent results with standard semaglutide timing